Back to Careers

Hanadie Yousef, Juvena’s CEO and co-founder, participated in #BiotechCEOSisterhood, #Breaking7%, and PINK Tuesday events, connecting with leaders and allies to drive innovation and collaboration

Back to Careers

Dr. Hanadie Yousef, CEO and co-founder of Juvena, and Dr. Austin Wang, Corporate Development Manager,  hosted an executive roundtable on weight loss for longevity at the #WuXiGlobalForum, fostering engaging discussions with industry leaders

Back to Careers

Juvena’s CEO and co-founder, Dr. Hanadie Yousef, shared insights on “Enhancing Longevity: Delaying the Diseases That Age Us” at the #BiotechShowcase panel and highlighted Juvena’s progress, including the upcoming clinical trials for JUV-161

Back to Careers

As a Tech Pioneer company, CEO Hanadie Yousef participated in the third Annual Meeting of the Innovator Communities at the World Economic Forum’s New York office, amongst over 80 Founders and CEOs

Back to Careers

CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled platform for mapping the therapeutic potential of stem cell secreted proteins and engineering restorative biologics for age-related and chronic diseases on the podcast Impact AI

Back to Careers

Dr. Jeremy O’Connell, our CSO, participated as a panelist at the Gerontological Society of America (GSA) Annual Meeting, discussing the role of NIA programs in advancing JUV-161 from discovery to development and fostering innovation in aging research

Back to Careers

CSO Dr. Jeremy O’Connell and Director Dr. Priya Handa represent Juvena and present our JUV-112 metabolic disease asset at Obesity Week 2024

Back to Careers

Thach Mai, Director of Discovery and Platform, and Priya Handa, Director of Translational Biology, were speakers at the 16th Drug Discovery Strategic Summit in San Francisco. Thach presented on our AI-enabled platform for therapeutic discovery, while Priya spoke about JUV-112, a novel approach to weight loss and metabolic health

Back to Careers

CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled proteomics and multimodal platform for decoding therapeutic secreted proteins on the “Leveraging Technology to Advance the Pipeline” panel at Longwood’s Boston CEO summit

Back to Careers

CEO Dr. Hanadie Yousef was nominated to Founders Forum’s 100 Women Founders to Watch,  which shines a light on 100 of the most exceptional women founders blazing a trail in the tech industry across UK & Europe, the United States, and Southeast Asia